Premier Diagnostic Health Services Inc.
CNSX : PDH

Premier Diagnostic Health Services Inc.

April 19, 2011 09:30 ET

PDH Adds to Its Market Development Team in China

VANCOUVER, BRITISH COLUMBIA--(Marketwire - April 19, 2011) -

NOT FOR DISSEMINATION IN THE UNITED STATES OF AMERICA

Premier Diagnostic Health Services Inc. (CNSX:PDH) announced today that it has engaged the exclusive services of Hua (Kathy) Su in China as Manager, Market Development, China.

Reporting to Leonhard Braunizer, Premier Director of International Sales, Kathy will be furthering the Company's market research for the identification and qualification of candidate hospitals to accomplish the Company's growth objectives in China.

Kathy brings 20 years working experience in China's healthcare industry. She has held high level management positions in diagnostic and pharmaceutical companies and as such has developed valuable relationships in both the Ministry of Health and the SFDA in China. Kathy has extensive knowledge regarding clinical trials and regulatory issues relating to medical devices and other products.

"We are very pleased to welcome Kathy to the team, and are confident that her experience will enhance the ongoing development of Premier's China Program," said Denis Tusar, Premier CEO.

The addition of Kathy Su compliments the clinical research and services company GeneDiagnostic Inc. in Hangzhou, China, to accelerate the Company's Market Development Program for China. GeneDiagnostic represents several international companies active in various aspects of cancer care working with hospitals in China. A senior representative of GeneDiagnostic will be visiting Premier in the first week of May to participate in the launch of the Program.

Previous discussions with a businessman in China, announced at the recent AGM, were not concluded to the satisfaction of the Company, and have therefore been terminated.

Except for historical information contained herein, this news release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by Premier.

About Premier Diagnostic Health Services Inc. ("PDH")

The company is engaged in developing and operating diagnostic imaging clinics in Canada and China, with a focus on PET-CT Scanning ("Positron Emission Tomography – Computed Tomography"). Premier is committed to providing the latest technology to enhance health options and owns and operates the first and only private PET-CT clinic in Western Canada as well as an MRI clinic in collaboration with Beijing AP Hospital No. 3 in China. The Centre for Advanced Diagnostics in Burnaby offers access to the most advanced medical imaging technology available in cancer care today, and is dedicated to meeting today's healthcare needs through delivering exceptional patient care.

The Canadian National Stock Exchange has neither approved nor disapproved the contents of this press release.

Contact Information